Anthem Biosciences Limited Board Meeting Scheduled to Approve Q1 Financial Results
Anthem Biosciences Limited, formerly known as Anthem Biosciences Private Limited, has announced a board meeting scheduled to review and approve its financial performance for the quarter ended June 30, 2026.The Board of Directors is slated to meet on Tuesday, July 21, 2026, with the primary agenda item being the consideration and approval of the Unaudited Standalone and Consolidated Financial Results for the period.
In addition to the board meeting announcement, the company also provided details regarding trading restrictions concerning its equity shares. The trading window has been closed from July 01, 2026, through close of trading hours on July 23, 2026. These restrictions are in compliance with the Company’s Code of Conduct and regulations designed to monitor and report trading by employees and other connected persons.
A2ZINFRA Stock Price Movement
On Tuesday, shares of A2Z Infra Engineering Limited rallied significantly, concluding the session at ₹14.01 after jumping 6.01% in the previous trading period. The equity traded within a range spanning from a low of ₹13.15 to a high of ₹14.46 and saw a total volume of 322,842 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.